Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02094872
Title Molecularly Targeted Therapy in Treating Patients With BRAF Wild-type Melanoma That is Metastatic
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Yale University
Indications
Therapies
Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST